stock

Incyte Corp. (INCY)

0
December 2nd, 2020

Share

Stay up to date

Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration and has been prescribed to patients in the United States.

Financial Statements

Key Info

  • Industry:
  • Sector:
  • CEO Name: Paul Friedman

Key Statistics

  • Stock Price: $85.42
  • Dividend Yield: 0%
  • Market Capitalization: $18,706,646,008
  • Shares Outstanding: 218,996,090
  • Number of Employees: 1,456
  • Trailing 12-Month EPS: $-0.88
  • Trailing 12-Month DPS: $0
  • Payout Ratio: -0.0%

Important Dates

  • Next Earnings Date:
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $85.42
  • 52-week high: $109.69
  • 52-week low: $63.18
  • 200-day moving average: $94.07
  • 50-day moving average: $85.6

Performance

  • 1-Month Price Return: -1.4%
  • 3-Month Price Return: -8.1%
  • 6-Month Price Return: -16.0%
  • 1-Year Price Return: -9.3%
  • 2-Year Price Return: 32.9%
  • 5-Year Price Return: -23.9%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

December 2nd, 2020